Medidata taps Gyro New York to launch brand campaign

Medidata, provider of analytics for clinical research, has chosen Gyro New York, part of Dentsu Aegis Network, as its creative agency after a formal review. The B2B shop is charged with shepherding Medidata’s new brand campaign, “Architecture of Hope.” 

The company, which provides cloud technology and data insights to streamline medical research and deliver better therapies to patients sooner, has tapped the agency’s global healthcare practice to roll out a series of integrated programs. The goal is to illustrate the important work of the life sciences industry, as well as spotlight the role that Medidata plays in the development of therapies for patients. 

“Gyro understands the complexity of the healthcare space, and we’re confident that together we will elevate our brand and communicate the value that our unified platform brings to the entire clinical trials ecosystem,” Simon Mouyal, CMO of Medidata said the press release.

The Medidata platform has been used by nearly 800 global customers around the world, supporting more than 12,000 clinical studies. The “Architecture of Hope” campaign is designed to highlight the company’s expertise in study planning, site support, patient engagement, study conduct and study outcome optimization.

“Our healthcare expertise was central to helping us understand not only the solutions themselves, but also the healthcare audiences and the higher purpose that Medidata serves,” said Wendy Lurrie, managing director of Gyro New York and Gyro:Human, in the statement.